- BLA based on data from the global Phase 1/2 CADENZA trial NORTH CHICAGO, Ill., Sept. 30, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced submission of a new Biologics License Application (BLA) to ...

For most people, one of the biggest concerns after a conviction is how it might affect their job. Many employers perform background checks before hiring, and a drug-related offense can raise red flags ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that the U.S. Food & Drug ...

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 02, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (HCM) (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announced that, Inmagene ...

The drug candidate demonstrates antipsychotic activity and has a mechanism of action distinct from FDA-approved therapies for schizophrenia and other mental conditions that present psychotic symptoms ...

Stock photo from Getty Images. The Ohio Board of Pharmacy on Tuesday suspended the license of a beauty spa after determining that it was giving patients dangerous drugs that lacked the proper ...